Literature DB >> 15942724

Long-term fibrate treatment for PBC.

Makoto Nakamuta, Munechika Enjoji, Kazuhiro Kotoh, Naoya Shimohashi, Yuichi Tanabe.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15942724     DOI： 10.1007/s00535-004-1583-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  9 in total

1.  Long-term effect of bezafibrate on parameters of hepatic fibrosis in primary biliary cirrhosis.

Authors:  Kenji Ohmoto; Naoko Yoshioka; Shinichiro Yamamoto
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

2.  Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis.

Authors:  Runalia Bahar; Kimberly A Wong; Chung H Liu; Christopher L Bowlus
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-03

Review 3.  New therapies for primary biliary cirrhosis.

Authors:  Annarosa Floreani; Irene Franceschet; Lisa Perini; Nora Cazzagon; M Eric Gershwin; Christopher L Bowlus
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

4.  Inhibition of JNK signalling mediates PPARα-dependent protection against intrahepatic cholestasis by fenofibrate.

Authors:  Manyun Dai; Julin Yang; Minzhu Xie; Jiao Lin; Min Luo; Huiying Hua; Gangming Xu; Hante Lin; Danjun Song; Yuqing Cheng; Bin Guo; Jinshun Zhao; Frank J Gonzalez; Aiming Liu
Journal:  Br J Pharmacol       Date:  2017-08-10       Impact factor: 8.739

Review 5.  Proposed therapies in primary biliary cholangitis.

Authors:  Annarosa Floreani; Ying Sun; Zheng Sheng Zou; Baosen Li; Nora Cazzagon; Christopher L Bowlus; M Eric Gershwin
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2016-01-06       Impact factor: 3.869

6.  Fenofibrate in primary biliary cirrhosis: a pilot study.

Authors:  E N Liberopoulos; M Florentin; M S Elisaf; D P Mikhailidis; E Tsianos
Journal:  Open Cardiovasc Med J       Date:  2010-04-28

Review 7.  Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy.

Authors:  Treta Purohit; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2015-05-08

8.  Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial.

Authors:  Ruth Bolier; Elsemieke S de Vries; Albert Parés; Jeltje Helder; E Marleen Kemper; Koos Zwinderman; Ronald P Oude Elferink; Ulrich Beuers
Journal:  Trials       Date:  2017-05-23       Impact factor: 2.279

9.  Incidence, mortality, and predictive factors of hepatocellular carcinoma in primary biliary cirrhosis.

Authors:  Kenichi Hosonuma; Ken Sato; Masatoshi Yanagisawa; Satoru Kakizaki; Hitoshi Takagi; Junko Hirato; Masatomo Mori
Journal:  Gastroenterol Res Pract       Date:  2013-02-25       Impact factor: 2.260
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.